Pieterjan Debie

10PUBLICATIONS
22CO-AUTHORS
Molecular targetsGlycoconjugatesNanomedicineMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 16, 2023
Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using a Fluorescently Labelled Anti-CEA Nanobody Probe: A Preclinical Study.

Labrinus van Manen, Lizzie D A N de Muynck, Victor M Baart

|Nov 02, 2021
Evaluation of single domain antibodies as nuclear tracers for imaging of the immune checkpoint receptor human lymphocyte activation gene-3 in cancer.

Q Lecocq, P Debie, J Puttemans

|Jul 26, 2021
Rapid tumor-labeling kinetics with a site-specific near-infrared anti-CEA nanobody in a patient-derived orthotopic xenograft mouse model of colon cancer.

Thinzar M Lwin, Michael A Turner, Siamak Amirfakhri

|Apr 30, 2021
Decorating sdAbs with Chelators: Effect of Conjugation on Biodistribution and Functionality.

Henri Baudhuin, Janik Puttemans, Heleen Hanssens

|Oct 02, 2020
Anti-human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical Translation.

Jessica Bridoux, Katrijn Broos, Quentin Lecocq

|Apr 25, 2020
Preclinical Targeted α- and β--Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies.

Janik Puttemans, Yana Dekempeneer, Jos L Eersels

Pageof 2

Frequent Collaborators

4 joint publications

Nick Devoogdt

3 joint publications

Quentin Lecocq

3 joint publications

Janik Puttemans

3 joint publications

Sophie Hernot